Register for our S/EIS Fund

Even the entrepreneurial and investment ecosystem has not been spared by the coronavirus. In our first exclusive global o2h ChaiTime webinar we quizzed our panelists on the future landscape for early stage investing in a post COVID-19 pandemic environment.

In the panel we had President and CEO of one of the largest healthcare technology companies, a seasoned start-up entrepreneur, an early stage Angel investor, a fund manager, a wealth manager and a start-up entrepreneur who has been featured for his AI platform that could lead to new therapeutic combinations against COVID-19.

The panelists
Kieran Murphy CEO of GE Healthcare

Kieran is a president and CEO of GE Healthcare, a leading global medical technology company employing 50,000 people around the globe.

Peyman Gifani CEO of AI VIVO

Peyman is CEO of AIVIVO, an AI platform to support discovery therapeutics.

Goncalo de Vasconcelos CEO of RNWL

Goncalo is CEO of RNWL and Founder of Syndicate Room.

Sanjeev Gordhan Commercial Director of Newable

Sanjeev is a Commercial Director of Newable, Technology EIS Fund.

Steve Thurlby Wealth Advisor of Fairstone Group

Steve Thurlby is a Wealth Management Advisor at Fairstone Group.

Deepali Nangia Angel investor

Deepali is an angel investor and advisor to female founders.

Sunil Shah CEO

A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.

Register for Invitations